Supported by Zhangjiakou Science and Technology Research and Development Program,No.1821154H;Zhangjiakou Technology Innovation Guidance Program,No.2021194H。
BACKGROUND Drug-eluting beads show good safety and promising efficacy when used as part of a transarterial chemoembolization regimen for primary liver cancer.However,data on the clinical efficacy and safety of pirarub...
This study was supported by the National Natural Science Foundation of China(81572375 and 81872024);the Chongqing Natural Science Foundation(cstc2018jcyjA2018).
Aim:Liver cancer is one of the most common malignancies and has a high recurrence rate.However,current treatment strategies do not achieve satisfactory outcomes in the clinic.To explore a new strategy to enhance the e...
Project of Hubei Provincial Natural Science Foundation ,No:(2012)30.
Objective: To study the effects of pirarubicin and mitoxantrone for bladder cancer perfusion chemotherapy on the expression of malignant molecules in serum and lavage fluid. Methods:Patients with advanced bladder canc...
Natural Science Foundation of China(30670612);China International Medical Foundation(Z-2014-06-15322);Navy Logistics Department(HJHQ-20130987).
Objective:To study the effect of licartin combined with pirarubicin transcatheter arterial chemoembolization (TACE) on apoptosis and epithelial - mesenchymal transition in unresectable liver cancer tissue.Methods: Pat...
Objective: To study the effect of interleukin-2 + pirarubicin infusion chemotherapy combined with systemic chemotherapy on the malignant biological behavior of advanced bladder cancer. Methods: Patients with advanced ...
Objective:Investigate the mechanism of Pirarubicin postoperative immediately bladder irrigation combined compound matrine injection on treating superficial bladder cancer, thus to provide assistance for clinical thera...
In the present study, we aimed to evaluate the efficiency and cost ofpirarubicin (THP) and epirubicin (EPI) as prophylaxis for recurrence in patients with superficial bladder tumors by bladder instillation after t...
Background Immediate intravesical instillation of chemotherapeutic agents after transurethral resection (TUR) of non- muscle invasive transitional cell bladder cancer has recently been suggested and has been proven ...
Aim: Pirarubicin (THP) is recently found to be effective in treating patients with advanced, relapsed or recurrent high-grade osteosarcoma. In this study, the effects of THP on the multidrug-resistant (MDR) osteo...
Background Superficial bladder cancer accounts for 60%-70% of all bladder cancer cases in China, when treatment consists of only transurethral resection of the bladder tumor (TUR-BT), recurrence and progresses in th...